With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes

Diabetes treatments available today include shots and pills intended to restore the hormone balance that leads to healthy blood sugar levels. Whole Biome aims to accomplish the same thing—but with a capsule that targets the gut microbiome.

Whole Biome is preparing to launch its product early next year. To support those plans, the San Francisco-based startup has closed $35 million in Series B funding, led by Sequoia Capital.